Search results for "BIOFILM"

showing 10 items of 394 documents

Voriconazole inhibits biofilm formation in different species of the genus Candida

2012

To determine the ability of voriconazole to inhibit the formation of biofilms.A total of 38 blood isolates of Candida spp. (8 Candida albicans, 10 Candida tropicalis, 10 Candida glabrata, 7 Candida parapsilosis sensu stricto and 3 Candida orthopsilosis) and C. albicans ATCC 90028 and ATCC 64548 were assessed. Biofilm formation was quantified using XTT reduction assays. The inhibition of biofilm formation was determined (i) in the presence of 0.06 and 0.25 mg/L voriconazole, and (ii) on surfaces previously coated with 0.06, 0.25, 1, 4 and 16 mg/L voriconazole.Voriconazole reduced biofilm formation under both conditions, the extent depending on the species, isolate and drug concentration. In …

Microbiology (medical)Antifungal AgentseducationTetrazolium SaltsBiologyCandida parapsilosisGenus CandidaMicrobiologymedicineHumansPharmacology (medical)Candida albicansSensu strictoCandidaPharmacologyVoriconazoleStaining and LabelingCandidiasisBiofilmTriazolesbiochemical phenomena metabolism and nutritionbiology.organism_classificationCorpus albicansPyrimidinesInfectious DiseasesBiofilmsCandida sppVoriconazolemedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria

2008

Abstract Background A study to evaluate the biofilm-development ability in three different media (Middlebrook 7H9, sterile tap water and PBS-5% glucose) was performed with 19 collection strains from 15 different species on non-pigmented rapidly growing mycobacteria (NPRGM). A microtiter plate assay was developed to evaluate the percentage of covered surface of the microtiter plate wells in different days from day 1 to day 69. Results All strains were able to develop biofilm in all the tested media. Middlebrook 7H9 showed the fastest growth, followed by sterile tap water and PBS-5% glucose. A sigmoid growth curve was detected in all the strains both in Middlebrook 7H9 and in sterile tap wate…

Microbiology (medical)Bacteriological TechniquesMicroscopy ConfocalModels Statisticallcsh:QR1-502BiofilmBiologyMicrobiologyBacterial Adhesionlcsh:MicrobiologyCulture MediaMycobacteriumMicrobiologyMicrotiter plateTap waterBiofilmsResearch ArticleBMC Microbiology
researchProduct

In vitro anti-Gram-positive and anti-staphylococcal biofilm activity of newly halogenated pyrroles related to Pyrrolomycins

2007

Microbiology (medical)ChemistryStaphylococcusBiofilmGeneral MedicineMicrobial Sensitivity Testshalogenated pyrroleGram-Positive Bacteriaantistaphylococcal biofilm activityIn vitroMicrobiologyAnti-Bacterial AgentsStructure-Activity RelationshipInfectious DiseasesVancomycinBiofilmsStructure–activity relationshipPharmacology (medical)PyrrolespyrrolomycinsGram
researchProduct

Phylogenetic analysis of environmental Legionella pneumophila isolates from an endemic area (Alcoy, Spain).

2015

Environmental surveillance of Legionella pneumophila is a key component of the control measures established in urban settlements to ensure water safety and quality, with the aim of minimizing and limiting opportunistic infections in humans. In this work, we present results on the detection and genetic characterization of these bacteria in the outbreak-recurrent region of Alcoy (Comunidad Valenciana, Spain) using water and biofilm samples. We were particularly interested in studying the presence and distribution of L. pneumophila in the absence of outbreak or sporadic cases of legionellosis and in comparing the efficacy of culturing from water samples with a biofilm-based detection procedure…

Microbiology (medical)DNA BacterialMicrobiological cultureEndemic DiseasesLegionellaTouchdown polymerase chain reactionMicrobiologyLegionella pneumophilaMicrobiologyLegionella pneumophilaGeneticsHumansMolecular BiologyEcology Evolution Behavior and SystematicsPhylogenybiologyBiofilmTemperatureOutbreakWaterbiology.organism_classificationPhylogeographyInfectious DiseasesSpainBiofilmsMultilocus sequence typingChlorineLegionnaires' DiseaseWater MicrobiologyBacteriaInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
researchProduct

Minimum information about a biofilm experiment (MIABiE): standards for reporting experiments and data on sessile microbial communities living at inte…

2014

The minimum information about a biofilm experiment (MIABiE) initiative has arisen from the need to find an adequate and scientifically sound way to control the quality of the documentation accompanying the public deposition of biofilm-related data, particularly those obtained using high-throughput devices and techniques. Thereby, the MIABiE consortium has initiated the identification and organization of a set of modules containing the minimum information that needs to be reported to guarantee the interpretability and independent verification of experimental results and their integration with knowledge coming from other fields. MIABiE does not intend to propose specific standards on how biof…

Microbiology (medical)Databases FactualStandardizationComputer sciencemedia_common.quotation_subjectControl (management)Microbial communitiesGuidelines as TopicDocumentationBioinformaticsArticleBasic medicine03 medical and health sciencesDocumentationData standardizationTerminology as Topic:Basic medicine [Medical and Health sciences]HumansImmunology and AllergyQuality (business)Data interchangeSet (psychology)030304 developmental biologyInterpretabilitymedia_common0303 health sciencesScience & TechnologyGeneral Immunology and Microbiology030306 microbiologyBiofilmResearchMachine-readable formatsComputational Biology:Medicina básica [Ciências médicas e da saúde]General MedicineData scienceMetadataIdentification (information)Infectious DiseasesVocabulary ControlledResearch DesignMedicina básicaBiofilmsSoftwarePathogens and Disease
researchProduct

Fungal Biofilms as a Valuable Target for the Discovery of Natural Products That Cope with the Resistance of Medically Important Fungi—Latest Findings

2021

The development of new antifungal agents that target biofilms is an urgent need. Natural products, mainly from the plant kingdom, represent an invaluable source of these entities. The present review provides an update (2017–May 2021) on the available information on essential oils, propolis, extracts from plants, algae, lichens and microorganisms, compounds from different natural sources and nanosystems containing natural products with the capacity to in vitro or in vivo modulate fungal biofilms. The search yielded 42 articles; seven involved essential oils, two Brazilian propolis, six plant extracts and one of each, extracts from lichens and algae/cyanobacteria. Twenty articles deal with th…

Microbiology (medical)FusariumCyanobacteriaFUNGAL BIOFILMnatural productsMicroorganism<i>Candida</i> spp.CryptococcusCANDIDA SPPRM1-950ReviewBiochemistryMicrobiologyCRYPTOCOCCUS SPPFUSARIUM SPPmechanisms of antibiofilm actionNATURAL PRODUCTSAspergillus fumigatusMicrobiology//purl.org/becyt/ford/1 [https]//purl.org/becyt/ford/1.4 [https]Pharmacology (medical)General Pharmacology Toxicology and PharmaceuticsLichenFusarium spp.ANTIFUNGAL RESISTANCECandida spp.MECHANISMS OF ANTIBIOFILM ACTIONbiology<i>Cryptococcus</i> spp.filamentous fungiBiofilmCryptococcus spp.PropolisFILAMENTOUS FUNGIantifungal resistancebiology.organism_classificationInfectious Diseases<i>Fusarium</i> spp.fungal biofilmTherapeutics. PharmacologyAntibiotics
researchProduct

3,4,5,3’,5’-pentabromo-2-(2’-hydroxybenzoyl) pyrrole: a potential lead compound as anti Gram-positive and anti biofilm agent

2005

The activity against Gram-positive bacteria of 3,4,5,3 ,5 -pentabromo-2-(2 -hydroxybenzoyl)pyrrole I, a synthetic anti-bacterial compound related to pyrrolomycins, was tested in vitro using seven reference bacterial strains and Staphylococcus epidermidis and Staphylococcus aureus preformed biofilms. Compound I was active against all strains tested, with minimum inhibitory concentration (MIC) values ranging from 0.002 to 0.097 mg/l and minimum bactericidal concentrations (MBCs) from 0.37 to 12.5 mg/l. Compound I was also active at low concentrations against preformed S. epidermidis and S. aureus biofilms.

Microbiology (medical)Gram-positive bacteriaTetrazolium SaltsMicrobial Sensitivity Testsmedicine.disease_causeGram-Positive BacteriaMicrobiologychemistry.chemical_compoundMinimum inhibitory concentrationStaphylococcus epidermidisDrug Resistance BacterialmedicineHumansPharmacology (medical)PyrrolesPyrrolebiologyAntimicrobici Staphylococci Anti-biofilmBiofilmAntimicrobici Staphylococci Anti-biofilmGeneral Medicinebiology.organism_classificationAnti-Bacterial AgentsHydrocarbons BrominatedThiazolesInfectious DiseaseschemistryStaphylococcus aureusBiofilmsGentian VioletLead compoundBacteria
researchProduct

A Novel Peptide with Antifungal Activity from Red Swamp Crayfish Procambarus clarkii

2022

The defense system of freshwater crayfish Procambarus clarkii as a diversified source of bioactive molecules with antimicrobial properties was studied. Antimicrobial activity of two polypeptide-enriched extracts obtained from hemocytes and hemolymph of P. clarkii were assessed against Gram positive (Staphylococcus aureus, Enterococcus faecalis) and Gram negative (Pseudomonas aeruginosa, Escherichia coli) bacteria and toward the yeast Candida albicans. The two peptide fractions showed interesting MIC values (ranging from 11 to 700 μg/mL) against all tested pathogens. Polypeptide-enriched extracts were further investigated using a high-resolution mass spectrometry and database search and 14 n…

Microbiology (medical)Infectious Diseasescrustacean antimicrobial peptides; antibiotic resistant strains; high-resolution mass spectrometry; antibiofilm activity; <i>Candida albicans</i>Candida albicansantibiofilm activityPharmacology (medical)crustacean antimicrobial peptideshigh-resolution mass spectrometryGeneral Pharmacology Toxicology and PharmaceuticsBiochemistryMicrobiologyantibiotic resistant strains
researchProduct

LC-QTOF-MS and 1H NMR Metabolomics Verifies Potential Use of Greater Omentum for Klebsiella pneumoniae Biofilm Eradication in Rats

2020

Bacterial wound infections are a common problem associated with surgical interventions. In particular, biofilm-forming bacteria are hard to eradicate, and alternative methods of treatment based on covering wounds with vascularized flaps of tissue are being developed. The greater omentum is a complex organ covering the intestines in the abdomen, which support wound recovery following surgical procedures and exhibit natural antimicrobial activity that could improve biofilm eradication. We investigated changes in rats&rsquo

Microbiology (medical)Klebsiella pneumoniae<i>Klebsiella pneumoniae</i>implantslcsh:Medicinemacromolecular substancesArticleMicrobiologysurgery03 medical and health sciencesmicrobial biofilm eradication0302 clinical medicinePeritoneummedicineMetabolomeImmunology and Allergy030212 general & internal medicineMolecular BiologyGeneral Immunology and Microbiologybiologyintegumentary systembusiness.industrylcsh:RBiofilmGreater omentumbiology.organism_classificationAntimicrobialmetabolomicsbody regionsKlebsiella pneumoniaeInfectious Diseasesmedicine.anatomical_structureImplantbusinessWound healing030217 neurology & neurosurgeryPathogens
researchProduct

Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria

2009

AbstractThe relationship between clinical significance of non-pigmented, rapidly growing mycobacteria (NPRGM), in vitro biofilm development and sliding motility was evaluated in this study. One hundred and sixty-eight clinical strains of NPRGM were included. Forty-one of these were clinically significant isolates. Biofilm was formed by 123 strains. Seventy-six biofilm-positive and 25 biofilm-negative strains showed sliding motility. There was a relationship between clinical significance and biofilm development (p <0.000 001), sliding motility (p 0.0037) and species (p <0.000 001). No relationship was found between motility and biofilm development. The ability to develop biofilm is a charact…

Microbiology (medical)Mycobacterium InfectionsbiologyBiofilmclinical significanceBiofilmMotilityGeneral MedicineMycobacterium InfectionsPigments Biologicalbiochemical phenomena metabolism and nutritionbiology.organism_classificationIn vitroMicrobiologyMycobacteriumInfectious DiseasesmotilityBiofilmsrapidly growing mycobacteriaHumansClinical significancemicrotitreBacteriaLocomotionMycobacteriumClinical Microbiology and Infection
researchProduct